Synonyms: Clexane® | enoxaparin sodium | Lovenox® | PK-10169 | RP-54563
enoxaparin is an approved drug (FDA (1993), FDA (2016))
Compound class:
Synthetic organic
Comment: A Low-Molecular-Weight Heparin antithrombin-III activator. It consists of fractionated material from pig mucosa but the PubChem structure represents the major form.
Biosimilar drugs: The EMA approved enoxaparin biosimilars named Inhixa and Thorinane in 2016. ![]() View more information in the IUPHAR Pharmacology Education Project: enoxaparin |
|
References |
1. de Haan CA, Li Z, te Lintelo E, Bosch BJ, Haijema BJ, Rottier PJ. (2005)
Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor. J Virol, 79 (22): 14451-6. [PMID:16254381] |
2. Eriksson BI, Söderberg K, Widlund L, Wandeli B, Tengborn L, Risberg B. (1995)
A comparative study of three low-molecular weight heparins (LMWH) and unfractionated heparin (UH) in healthy volunteers. Thromb Haemost, 73 (3): 398-401. [PMID:7667822] |
3. Lang J, Yang N, Deng J, Liu K, Yang P, Zhang G, Jiang C. (2011)
Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. PLoS ONE, 6 (8): e23710. [PMID:21887302] |